tiprankstipranks
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market
ANTH
Anthera Pharmaceuticals
RESEARCH TOOLSreports
Want to see ANTH full AI Analyst Report?

Anthera Pharmaceuticals (ANTH) Income Statement

238 Followers

Anthera Pharmaceuticals Income Statement

Last quarter (Q1 2018), Anthera Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Anthera Pharmaceuticals's net income was $-4.43M. See Anthera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 17
Total Revenue
$ 0.00
Gross Profit
$ -281.00K
Operating Expenses
$ 36.53M
Depreciation and Amortization
$ 281.00K
EBITDA
$ -26.59M
Operating Income
$ -36.43M
Other Income/Expenses
$ 9.56M
Pretax Income
$ -26.87M
Net Income
$ -16.93M
Per Share Metrics
Basic EPS
$ -1.65
Diluted EPS
$ -1.65
Weighted Average Shares Outstanding
 10.28M
Weighted Average Shares Outstanding (Diluted)
 10.28M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History